Simulations Plus, Inc. (NASDAQ:SLP) Receives $51.40 Consensus Price Target from Analysts

Shares of Simulations Plus, Inc. (NASDAQ:SLP) have earned an average rating of “Buy” from the seven ratings firms that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $49.00.

Several analysts recently commented on the company. BTIG Research dropped their price target on Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research report on Thursday, October 24th. Stephens started coverage on shares of Simulations Plus in a report on Friday, November 15th. They set an “overweight” rating and a $39.00 target price for the company. StockNews.com downgraded shares of Simulations Plus from a “hold” rating to a “sell” rating in a research note on Monday, November 4th. William Blair restated an “outperform” rating on shares of Simulations Plus in a research report on Wednesday. Finally, KeyCorp cut their price objective on shares of Simulations Plus from $40.00 to $35.00 and set an “overweight” rating for the company in a report on Wednesday.

Insider Transactions at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $31.76, for a total value of $635,200.00. Following the sale, the director now directly owns 3,442,584 shares of the company’s stock, valued at approximately $109,336,467.84. The trade was a 0.58 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 19.40% of the company’s stock.

Institutional Trading of Simulations Plus

A number of institutional investors and hedge funds have recently added to or reduced their stakes in SLP. JPMorgan Chase & Co. increased its stake in Simulations Plus by 106.0% during the third quarter. JPMorgan Chase & Co. now owns 47,365 shares of the technology company’s stock worth $1,517,000 after purchasing an additional 24,371 shares during the period. Principal Financial Group Inc. grew its holdings in shares of Simulations Plus by 2.6% in the third quarter. Principal Financial Group Inc. now owns 87,273 shares of the technology company’s stock valued at $2,794,000 after purchasing an additional 2,226 shares in the last quarter. Franklin Resources Inc. increased its stake in Simulations Plus by 7.6% during the 3rd quarter. Franklin Resources Inc. now owns 10,797 shares of the technology company’s stock worth $342,000 after buying an additional 766 shares during the period. Barclays PLC lifted its holdings in Simulations Plus by 390.6% during the 3rd quarter. Barclays PLC now owns 28,473 shares of the technology company’s stock worth $911,000 after buying an additional 22,669 shares in the last quarter. Finally, Geode Capital Management LLC lifted its holdings in Simulations Plus by 4.4% during the 3rd quarter. Geode Capital Management LLC now owns 448,618 shares of the technology company’s stock worth $14,367,000 after buying an additional 18,924 shares in the last quarter. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Simulations Plus Stock Down 7.2 %

Shares of NASDAQ SLP opened at $28.21 on Tuesday. The firm has a market cap of $566.60 million, a price-to-earnings ratio of 57.57 and a beta of 0.80. The company’s 50-day simple moving average is $29.81 and its 200-day simple moving average is $33.96. Simulations Plus has a 52-week low of $24.00 and a 52-week high of $51.22.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings data on Wednesday, October 23rd. The technology company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.02. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. The company had revenue of $18.70 million for the quarter, compared to analysts’ expectations of $19.73 million. During the same period in the previous year, the firm posted $0.18 EPS. Simulations Plus’s revenue was up 19.9% compared to the same quarter last year. Equities research analysts anticipate that Simulations Plus will post 1.1 EPS for the current fiscal year.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.